Table 3.
Characterisitics | Stable disease group (n = 58) |
Progress disease group (n = 11) |
P |
---|---|---|---|
Age | 57.6 ± 12.3 | 67.9 ± 11.2 | 0.012 |
Gender, n (%) | 0.053 | ||
Male | 9 (17.6%) | 8 (44.4%) | |
Female | 42 (82.4%) | 10 (55.6%) | |
Tumor location, n (%) | |||
Cardia | 7 (12.1%) | 0 | 0.587 |
Fundus | 39 (67.2%) | 4 (36.4%) | 0.087 |
Body | 11 (19.0%) | 7 (63.6%) | 0.005 |
Antrum | 1 (1.7%) | 0 | 1.000 |
Initial diameter (mm) | 8.07 ± 3.11 | 12.55 ± 4.16 | 0.000 |
Initial EUS, n (%) | 0.509 | ||
Low risk | 55 (94.8%) | 10 (90.9%) | |
High risk | 3 (5.2%) | 1 (9.1%) | |
F/u EUS, n (%) | 0.001 | ||
Low risk | 53 (91.4%) | 6 (54.5%) | |
High risk | 5 (8.6%) | 5 (45.5%) | |
Growth rate per year (%) | −1.2 ± 9.7 | 50.7 ± 33.6 | 0.000 |